Table 1.

Characteristics and clinical parameters of participants

PCa-TMA Description	Clinical parameters	# of Cases
Tissues	BPH	34
	PCa	165
PCa	Gleason ≤ 6	33
	Gleason 7	100
	Gleason ≥ 8	32
Clinical Stage	Stage I	3
	Stage II	86
	Stage III	47
	Stage IV	18
	Unknown	11
Metastatic PCa	Organ Confined	141
	Metastatic PCa	13
	Unknown	11
Smoking	Tobacco/cigar/others	52
	Non-smoking	56
	Unknown	57
Recurrence	Local/Distal Recurrence	31
	No Recurrence	82
	Unknown	52
PSA	< 10 ng/ml	3
	10–20 ng/ml	4
	> 20 ng/ml	66
Age range (years)	BPH	57–81
	PCa	41–75